Dimensional Fund Advisors
OKUR

Dimensional Fund Advisors’s OnKure Therapeutics OKUR Stock Holding History

Dimensional Fund Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+68,563
New +$294K ﹤0.01% 3023
2024
Q4 		– Sell
-1,333
Closed -$22.7K – 3371
2024
Q3 		$22.7K Hold
1,333
– – ﹤0.01% 3330
2024
Q2 		$20.1K Hold
1,333
– – ﹤0.01% 3351
2024
Q1 		$22.1K Hold
1,333
– – ﹤0.01% 3362
2023
Q4 		$21.3K Sell
1,333
-3,650
-73% -$227K ﹤0.01% 3385
2023
Q3 		$379K Sell
4,983
-370
-7% -$25.2K ﹤0.01% 3098
2023
Q2 		$351K Buy
5,353
+1,651
+45% +$133K ﹤0.01% 3133
2023
Q1 		$221K Buy
+3,702
New +$134K ﹤0.01% 3185
2022
Q3 		$62K Buy
+1,842
New +$60.5K ﹤0.01% 3381

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's OKUR Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 68,563 shares worth $312K. The stake represents ﹤0.01% of the portfolio and ranks #3023 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in OKUR as recently as Q3 2024.

Dimensional Fund Advisors first reported a position in OKUR in Q3 2022 and has held it in 9 quarters since. The position peaked at $379K in Q3 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Dimensional Fund Advisors held 68,563 shares of OnKure Therapeutics worth $312K as of Q2 2026.
  • OnKure Therapeutics was a new Dimensional Fund Advisors position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3023 holding.
  • Dimensional Fund Advisors first reported a position in OnKure Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • Dimensional Fund Advisors's OnKure Therapeutics position peaked at $379K in Q3 2023.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.